ZA200707348B - A catheter lock solution comprising citrate and a paraben - Google Patents

A catheter lock solution comprising citrate and a paraben

Info

Publication number
ZA200707348B
ZA200707348B ZA200707348A ZA200707348A ZA200707348B ZA 200707348 B ZA200707348 B ZA 200707348B ZA 200707348 A ZA200707348 A ZA 200707348A ZA 200707348 A ZA200707348 A ZA 200707348A ZA 200707348 B ZA200707348 B ZA 200707348B
Authority
ZA
South Africa
Prior art keywords
paraben
lock solution
citrate
solution
catheter
Prior art date
Application number
ZA200707348A
Other languages
English (en)
Inventor
Ash Stephen
Steczko Janusz
Gary L Swanson
Original Assignee
Ash Access Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ash Access Technology Inc filed Critical Ash Access Technology Inc
Publication of ZA200707348B publication Critical patent/ZA200707348B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/10—Aromatic or araliphatic carboxylic acids, or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200707348A 2005-02-08 2006-02-02 A catheter lock solution comprising citrate and a paraben ZA200707348B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/053,130 US7749529B2 (en) 2005-02-08 2005-02-08 Catheter lock solution comprising citrate and a paraben

Publications (1)

Publication Number Publication Date
ZA200707348B true ZA200707348B (en) 2008-12-31

Family

ID=36563297

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707348A ZA200707348B (en) 2005-02-08 2006-02-02 A catheter lock solution comprising citrate and a paraben

Country Status (22)

Country Link
US (4) US7749529B2 (xx)
EP (1) EP1688154B1 (xx)
JP (1) JP5101019B2 (xx)
KR (1) KR101337312B1 (xx)
CN (1) CN101442956B (xx)
AT (1) ATE453415T1 (xx)
AU (1) AU2006212946B2 (xx)
BR (1) BRPI0606969A2 (xx)
CA (1) CA2597055C (xx)
CL (1) CL2007002304A1 (xx)
DE (1) DE602006011376D1 (xx)
DK (1) DK1688154T3 (xx)
ES (1) ES2337821T3 (xx)
HK (1) HK1094323A1 (xx)
IL (1) IL185120A (xx)
MX (1) MX2007009540A (xx)
PL (1) PL1688154T3 (xx)
PT (1) PT1688154E (xx)
RU (1) RU2399375C2 (xx)
SI (1) SI1688154T1 (xx)
WO (1) WO2006086250A2 (xx)
ZA (1) ZA200707348B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092890A1 (en) * 2001-05-10 2004-05-13 Ash Stephen R. Catheter lock solution including a photo-oxidant
KR20100102745A (ko) 2001-11-26 2010-09-24 제넨테크, 인크. 카테터 조성물 및 그의 용도
DE10261241A1 (de) * 2002-12-20 2004-07-15 3M Espe Ag Dentalmaterial mit bakteriostatischen und/oder bakteriziden Substanzen
US20040122126A1 (en) * 2002-12-20 2004-06-24 Dong Wu Free-radical initiator systems containing enzymes, compositions, and methods
US20040120901A1 (en) * 2002-12-20 2004-06-24 Dong Wu Dental compositions including enzymes and methods
US7749529B2 (en) * 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
EP1787627A1 (en) * 2005-11-17 2007-05-23 3M Innovative Properties Company Anti-microbial dental impression material
US8167847B2 (en) 2006-06-22 2012-05-01 Excelsior Medical Corporation Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
WO2008070353A2 (en) * 2006-11-07 2008-06-12 Genentech, Inc. Tissue plasminogen activator variant uses
ES2559633T3 (es) * 2007-01-29 2016-02-15 Mitsubishi Electric Corporation Dispositivo de visualización de imágenes y método de visualización de imágenes
US20080279907A1 (en) * 2007-05-10 2008-11-13 Ash Access Technology, Inc. Antimicrobial medical devices and methods for making and using same
JP5417691B2 (ja) * 2007-07-19 2014-02-19 株式会社ジェイ・エム・エス 弱酸を含有する血管内留置カテーテルのロック溶液
US8389583B2 (en) * 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use
BRPI0915241A2 (pt) 2008-11-12 2018-02-06 D Cary Douglas composição de trava, método de manutenção da desobstrução de um dispositivo de acesso vascular ou dispositivo de fornecimento intravascular e kit
CN102238955B (zh) * 2008-12-05 2014-05-07 株式会社Jms 含有弱酸的血管内留置导管的锁定溶液及容纳有该锁定溶液的容器
EP2391632B1 (en) * 2009-01-27 2017-11-15 Teleflex Medical Incorporated Bacteriostatic catheter lock containing glycerol
JP5412857B2 (ja) * 2009-02-03 2014-02-12 株式会社ジェイ・エム・エス 静菌効果を有するカテーテルロック液と該カテーテルロック液の調製方法
US9248093B2 (en) * 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
DE102009037492A1 (de) 2009-08-13 2011-06-30 Affeld, Klaus, Prof. Dr.-Ing., 10629 Zentralvenöser Katheter
CN106236708B (zh) 2009-11-17 2020-06-26 迈克尔·A·福兰 含游离脂肪酸的抗微生物组合物
EP2503883B1 (en) * 2009-11-24 2016-03-02 Fresenius Medical Care Deutschland GmbH Disinfectant composition
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
JP6174014B2 (ja) * 2011-05-27 2017-08-02 ズーレックス ファーマグラ インコーポレイテッド 哺乳動物乳頭の治療方法及び関連する組成物
WO2013049033A1 (en) * 2011-09-26 2013-04-04 Cary Douglas D Bladder catheter irrigation method and composition
US20130150828A1 (en) * 2011-12-08 2013-06-13 Rochester Medical Corporation Antifungal catheter
WO2014004498A1 (en) * 2012-06-25 2014-01-03 Medical Components, Inc. Citrate anticoagulant underloaded syringe for catheter locking
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US9750928B2 (en) * 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
CN103357105A (zh) * 2013-07-24 2013-10-23 王亮 限制接触型侧球囊双孔导尿管
JP2014024870A (ja) * 2013-11-06 2014-02-06 Jms Co Ltd 静菌効果を有するカテーテルロック液と該カテーテルロック液の調製方法
WO2015077798A1 (en) * 2013-11-25 2015-05-28 Excelsior Medical Corporation Catheter lock solution formulations
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
WO2016033234A1 (en) 2014-08-26 2016-03-03 C.R. Bard, Inc Urinary catheter
EP3307374A4 (en) 2015-06-11 2019-04-10 Proviflo, LLC GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES AND METHODS
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
ES2764760T3 (es) * 2015-11-05 2020-06-04 Univ Texas Soluciones antimicrobianas con estabilidad mejorada
AU2017217011B2 (en) * 2016-02-12 2021-06-03 Medical Components, Inc. Catheter locking solution and catheter locking therapy
CN106075718A (zh) * 2016-06-17 2016-11-09 北京远方通达医药技术有限公司 一种含有枸橼酸盐的封管器
US20190232006A1 (en) * 2016-07-08 2019-08-01 Hamad Medical Corporation Endotracheal tube system
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US10173035B2 (en) 2016-12-27 2019-01-08 Vasonics, Llc Catheter housing
EP3675779A4 (en) 2017-09-19 2020-07-08 C.R. Bard, Inc. URINARY CATHETER BRIDGE DEVICE, RELATED SYSTEMS AND METHODS
CA3076366C (en) 2017-09-22 2023-05-16 Becton, Dickinson And Company 4% trisodium citrate solution for use as a catheter lock solution
WO2019104162A1 (en) * 2017-11-25 2019-05-31 Ash Access Technology, Inc. Catheter lock solution comprising sodium citrate and benzyl alcohol
CN108578792A (zh) * 2018-05-17 2018-09-28 北京康博特森科技有限公司 一种抗凝剂及其应用
RU2765741C1 (ru) * 2021-02-26 2022-02-02 Общество с ограниченной ответственностью "Многопрофильный ветеринарный центр "Пёс и Кот" (ООО МВЦ "Пёс и Кот") Способ гемодиализа у собак весом 8 и более кг

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225254A (en) 1977-03-17 1980-09-30 Holberg Steven E Surgical scrub system
US4187719A (en) * 1977-08-11 1980-02-12 B. Braun Melsungen Aktiengesellschaft Apparatus to determine the sedimentation rate of red blood cells
US4193980A (en) * 1978-01-05 1980-03-18 Corning Glass Works Dry preparation for reticulocyte staining
US4225669A (en) * 1979-04-27 1980-09-30 Melnick Joseph L Staining and analysis of bacteria
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
US4885855A (en) * 1982-09-29 1989-12-12 Fearing Manufacturing Co., Inc. Antibacterial attachment
US5088996A (en) * 1984-04-16 1992-02-18 Kopfer Rudolph J Anti-aerosoling drug reconstitution device
US4677143A (en) * 1984-10-01 1987-06-30 Baxter Travenol Laboratories, Inc. Antimicrobial compositions
DE3622089A1 (de) 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US4929242A (en) * 1986-11-26 1990-05-29 Baxter International Inc. Solution and method for maintaining patency of a catheter
US4853227A (en) * 1987-10-23 1989-08-01 Ciba-Geigy Corporation Transdermal administration of a systemic active agent to a premature neonatal infant
DE3812524A1 (de) * 1988-04-15 1989-10-26 Fresenius Ag Dialysier- und spuelloesung fuer die intraperitoneale verabreichung mit antimikrobieller ausruestung
US4950665A (en) * 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
CA2003856C (en) * 1988-11-25 1996-01-30 Toshio Satoh Therapeutic agent for renal disorders
DK708488D0 (da) 1988-12-20 1988-12-20 Nordisk Gentofte Faktor i praeparat
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
US5032615A (en) * 1989-10-31 1991-07-16 The Regents Of The University Of California Continuous hemodialysis using citrate
US4973328A (en) * 1989-11-20 1990-11-27 Gerard Smith Closed system administering assembly
US5103817A (en) * 1990-07-20 1992-04-14 Xomed-Treace Inc. Automatic dye dispersant for endotracheal tubes and catheters
US5624414A (en) * 1992-02-18 1997-04-29 St. Francis Research Institute Needleless straight infusion port
US5647855A (en) * 1992-05-06 1997-07-15 Trooskin; Stanley Z. Self-healing diaphragm in a subcutaneous infusion port
US5378227A (en) * 1992-08-11 1995-01-03 Cobe Laboratories, Inc. Biological/pharmaceutical method and apparatus for collecting and mixing fluids
US6207107B1 (en) * 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5436007A (en) * 1992-10-23 1995-07-25 Abbott Laboratories Diaper rash lotion
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US6034133A (en) 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
US8241259B2 (en) 1994-06-14 2012-08-14 Innovation Technologies, Inc. Wound irrigation device and method
SI9400289A (en) * 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.
US6239048B1 (en) 1994-12-28 2001-05-29 Fibermark, Inc. Light-activated antimicrobial and antiviral materials
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
DE69637240T2 (de) * 1995-06-30 2008-06-12 P & PF Co., Ltd., Ibaraki Antibakterielles/bakterizides/antiseptisches mittel, dermatologische zubereitung und tensidzusammensetzung
US5709672A (en) * 1995-11-01 1998-01-20 Texas Tech University Health Sciences Center Silastic and polymer-based catheters with improved antimicrobial/antifungal properties
US5843016A (en) * 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
DE19612057A1 (de) 1996-03-27 1997-10-02 Antiseptica Chem Pharm Prod Gm Händedesinfektionsmittel
US5858641A (en) * 1996-09-17 1999-01-12 Shanbrom Technologies, Llc Disinfectant dye removal from blood and blood fractions using a porous poly(vinyl alcohol-acetal) copolymer
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
US5811741A (en) * 1997-03-19 1998-09-22 Coast Machinery, Inc. Apparatus for placing geophones beneath the surface of the earth
US6488665B1 (en) 1997-04-08 2002-12-03 Allegiance Corporation Antimicrobial alcohol gel pre-operative skin-preparation delivery system
US6361786B1 (en) * 1997-09-15 2002-03-26 Shanbrom Technologies Microbicide treated polymeric materials
US5811471A (en) * 1997-09-15 1998-09-22 Shanbrom Technologies Llc Disinfectant plastic sponge material
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6361524B1 (en) * 1998-04-14 2002-03-26 Becton, Dickinson And Company Syringe assembly
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
WO2000010385A1 (en) 1998-08-25 2000-03-02 Ash Medical Systems, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
US6958049B1 (en) * 1998-08-25 2005-10-25 Ash Access Technology, Inc. Method of enhancing catheter patency using a citrate salt catheter lock solution
US6190371B1 (en) * 1999-01-15 2001-02-20 Maginot Vascular Systems Catheter system having retractable working catheter and associated method
US6423329B1 (en) 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
CN1086592C (zh) * 1999-02-12 2002-06-26 中国人民解放军第四五五医院 抗菌抗凝硅胶导管
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
US6679870B1 (en) * 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) * 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
WO2001024825A2 (en) * 1999-10-01 2001-04-12 The General Hospital Corporation Doing Business As Massachusetts General Hospital Significance of dosimetry in photodynamic therapy of injured arteries
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
WO2001085249A1 (en) 2000-05-10 2001-11-15 Ash Medical Systems, Inc. A catheter lock solution including a photo-oxidant
AU2001274908A1 (en) * 2000-05-24 2001-12-03 Uab Research Foundation Use of citrate-containing dialysate for renal dialysis treatment
US6423050B1 (en) * 2000-06-16 2002-07-23 Zbylut J. Twardowski Method and apparatus for locking of central-vein catheters
US6451003B1 (en) * 2000-08-16 2002-09-17 Biolink Corporation Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
ATE368380T1 (de) * 2001-01-12 2007-08-15 Univ Texas Neue antiseptische derivate mit breitem antimikrobiellem wirkungsspektrum zur imprägnierung von oberflächen
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
WO2002085387A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
US20040092890A1 (en) * 2001-05-10 2004-05-13 Ash Stephen R. Catheter lock solution including a photo-oxidant
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
US6909030B2 (en) * 2001-10-15 2005-06-21 Cedars-Sinai Medical Center PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
EP1490140B1 (en) * 2002-03-14 2008-06-25 Ash Access Technology, Inc. Medical devices exhibiting antibacterial properties
CN101461982B (zh) * 2002-04-01 2012-06-27 Nd合伙人股份有限公司 克服植入器具周围的组织袋中的感染的装置
CN1301110C (zh) * 2002-04-01 2007-02-21 Nd合伙人股份有限公司 包含牛磺酰胺衍生物及羧酸和/或其盐的抗微生物闭锁
US6962714B2 (en) 2002-08-06 2005-11-08 Ecolab, Inc. Critical fluid antimicrobial compositions and their use and generation
US20040219179A1 (en) 2002-09-20 2004-11-04 Mcdaniel David H. Skin abrasive agents
CA2515657C (en) 2003-02-11 2015-06-23 Dilip Tapadiya, M.D., Inc. Wound irrigation equipment
US6729786B1 (en) 2003-03-14 2004-05-04 Mediflex Hospital Products, Inc. Liquid applicator for coloring a liquid
MXPA05011035A (es) 2003-04-16 2006-03-17 Neochemical Desarrollos Avanza Uso de un peroxido de dialquil cetona como agente biocida: esterilizante, antiseptico, desinfectante y parasiticida.
EP1644024B1 (en) * 2003-06-06 2019-07-31 Board of Regents, The University of Texas System Antimicrobial flush solutions
CA2538119C (en) 2003-09-09 2013-05-14 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
CA2541299A1 (en) 2003-10-07 2005-04-14 Renovis, Inc. Amide compounds as ion channel ligands and uses thereof
CA2552911A1 (en) * 2004-01-20 2005-08-11 Board Of Regents, The University Of Texas System Methods for coating and impregnating medical devices with antiseptic compositions
US7784424B2 (en) 2004-11-22 2010-08-31 Belanger Industrial Products, Inc. Heated towel dispenser
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
US20060204466A1 (en) 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060264423A1 (en) 2005-05-20 2006-11-23 Bioenvision, Inc. Methylene Blue Therapy of Viral Disease
WO2007038201A1 (en) 2005-09-23 2007-04-05 Bioenvision, Inc. Methylene blue therapy of parasitic infections
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US20070207113A1 (en) 2006-02-10 2007-09-06 Melissa Joerger Personal care and cosmetic compositions comprising renewably-based, biodegradable 1,3-propanediol
EP1986790B1 (en) 2006-02-14 2021-05-19 Allegiance Corporation Liquid applicator and method for reducing the concentration of by-products from antiseptic
US20100010086A1 (en) 2006-08-04 2010-01-14 Ash Stephen R Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
US20080279907A1 (en) 2007-05-10 2008-11-13 Ash Access Technology, Inc. Antimicrobial medical devices and methods for making and using same
US8389583B2 (en) 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use

Also Published As

Publication number Publication date
WO2006086250A2 (en) 2006-08-17
CL2007002304A1 (es) 2008-06-06
KR101337312B1 (ko) 2013-12-06
WO2006086250A3 (en) 2007-11-15
MX2007009540A (es) 2008-02-21
JP5101019B2 (ja) 2012-12-19
US20120277314A1 (en) 2012-11-01
US20100240750A1 (en) 2010-09-23
EP1688154A1 (en) 2006-08-09
PL1688154T3 (pl) 2010-06-30
CA2597055A1 (en) 2006-08-17
RU2007133649A (ru) 2009-03-20
AU2006212946B2 (en) 2012-06-28
CN101442956A (zh) 2009-05-27
DK1688154T3 (da) 2010-05-03
US9011897B2 (en) 2015-04-21
IL185120A (en) 2014-06-30
CN101442956B (zh) 2014-05-07
BRPI0606969A2 (pt) 2009-07-28
US8226971B2 (en) 2012-07-24
ATE453415T1 (de) 2010-01-15
US20130178526A1 (en) 2013-07-11
RU2399375C2 (ru) 2010-09-20
PT1688154E (pt) 2010-03-26
HK1094323A1 (en) 2007-03-30
IL185120A0 (en) 2008-01-20
DE602006011376D1 (de) 2010-02-11
CA2597055C (en) 2013-10-15
ES2337821T3 (es) 2010-04-29
US7749529B2 (en) 2010-07-06
US20060177477A1 (en) 2006-08-10
EP1688154B1 (en) 2009-12-30
SI1688154T1 (sl) 2010-05-31
JP2006232829A (ja) 2006-09-07
KR20070114737A (ko) 2007-12-04
AU2006212946A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
HK1094323A1 (en) A catheter lock solution comprising citrate and a paraben
WO2008019083A3 (en) Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
AU2001263044A1 (en) A catheter lock solution including a photo-oxidant
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2006063176A3 (en) Inhibition of biofilm formation using bacteriophage
EP2261236A3 (en) Composition for proteasome inhibition
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2006012527A8 (en) Bivalent linkers and conjugates thereof
WO2008092006A3 (en) Antimicrobial compositions
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
EP1749517B8 (en) Stable pharmaceutical composition comprising linezolid form IV
WO2008005651A3 (en) Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
EP1627635A3 (en) Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
ATE524469T1 (de) Alkinylarylverbindungen und salze davon, diese enthaltende pharmazeutische zusammensetzungen, verfahren zu deren herstellung und deren verwendungen
CA2518971A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
ATE495735T1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO2010110908A3 (en) Transdermal venous access locking solution
WO2008005059A3 (en) Treatment of mouth and urinary tract infections
WO2007033508A3 (en) Organic compounds
WO2002005873A3 (en) Devices and methods for infusing a liquid into a catheter
WO2008001278A3 (en) Extracts of plectranthus hadiensis, argenatus or myrianthus for the treatment of microbial infection
WO2006124358A3 (en) Method of treating a coccidioides infection by administering an ambruticin compound
UA69966A (en) Forceps for passing ballooned probe into vascular lumen